Search hospitals > Minnesota > Minneapolis
CCOP - Metro-Minnesota
Claim this profileMinneapolis, Minnesota 55416
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Recurrence
536 reported clinical trials
6 medical researchers
Summary
CCOP - Metro-Minnesota is a medical facility located in Minneapolis, Minnesota. This center is recognized for care of Breast Cancer, Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Recurrence and other specialties. CCOP - Metro-Minnesota is involved with conducting 536 clinical trials across 400 conditions. There are 6 research doctors associated with this hospital, such as Daniel M. Anderson, Yan Ji, Arkadiusz Dudek, MD, and Joseph W. Leach.Area of expertise
1Breast Cancer
Global LeaderER positive
HER2 negative
Stage II
2Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Daniel M. AndersonRegions Hospital4 years of reported clinical research
Expert in Cancer
Expert in Tumors
60 reported clinical trials
108 drugs studied
Yan JiRegions Hospital1 year of reported clinical research
Expert in Cancer
Studies Breast Cancer
30 reported clinical trials
74 drugs studied
Arkadiusz Dudek, MDRegions Cancer Care Center4 years of reported clinical research
Studies Solid Tumors
Studies Melanoma
14 reported clinical trials
23 drugs studied
Joseph W. LeachMetro Minnesota Community Oncology Research Consortium12 years of reported clinical research
Studies Ovarian Cancer
Studies Fallopian Tube Carcinoma
1 reported clinical trial
5 drugs studied
Clinical Trials running at CCOP - Metro-Minnesota
Gastroesophageal Junction Adenocarcinoma
Gastric Cancer
Cancer
Breast Cancer
Lymphoma
Follicular Lymphoma
Tumors
Lung Cancer
Blood Cancers
B-Cell Lymphoma
Ramucirumab + Trifluridine/Tipiracil or Paclitaxel
for Gastric Cancer
This phase II trial studies the effect of the combination of ramucirumab and trifluridine/tipiracil or paclitaxel in treating patients with previously treated gastric or gastroesophageal junction cancer that has spread to other places in the body (advanced). Ramucirumab may damage tumor cells by targeting new blood vessel formation. Trifluridine/tipiracil is a chemotherapy pill and that may damage tumor cells by damaging their deoxyribonucleic acid (DNA). Paclitaxel may block cell growth by stopping cell division which may kill tumor cells. Giving ramucirumab and trifluridine/tipiracil will not be worse than ramucirumab and paclitaxel in treating gastric or gastroesophageal junction cancer.
Recruiting1 award Phase 21 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at CCOP - Metro-Minnesota?
CCOP - Metro-Minnesota is a medical facility located in Minneapolis, Minnesota. This center is recognized for care of Breast Cancer, Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Recurrence and other specialties. CCOP - Metro-Minnesota is involved with conducting 536 clinical trials across 400 conditions. There are 6 research doctors associated with this hospital, such as Daniel M. Anderson, Yan Ji, Arkadiusz Dudek, MD, and Joseph W. Leach.
Where is CCOP - Metro-Minnesota located?
The CCOP at Metro-Minnesota hospital is conveniently situated at 3800 Park Nicollet Blvd, Minneapolis, MN 55416, just a 15-minute drive from downtown Minneapolis via I-394 W and MN-100 N.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance-related inquiries in Minnesota, contact the Minnesota Department of Human Services at 651-431-6500 for information on health care programs including Medicaid and MinnesotaCare. HealthPartners offers a Financial Assistance Program for eligible individuals; call 651-265-1999 or 877-655-2669 (toll-free) to apply. The MetroHealth System provides financial assistance based on the Federal Poverty Guidelines, available at 216-957-2325, Option 1, Monday - Friday, 8 a.m. to 5 p.m. M Health Fairview also offers financial assistance; contact them at 612-672-2000 for more information.
What insurance does CCOP - Metro-Minnesota accept?
CCOP - Metro-Minnesota accepts a wide range of insurance plans, including Original Medicare, Medicare Advantage Plans (with and without Drug Coverage), Medicare Health Plans with Supplemental Coverage (Medigap), and Accepted Commercial Plans. For details on specific commercial plans accepted, please contact the hospital directly or verify with your plan administrator for coverage confirmation at an Allina Health facility.
What awards or recognition has CCOP - Metro-Minnesota received?
The Metro-Minnesota Community Oncology Research Consortium (MMCORC), renowned for its extensive history in cancer research and care, collaborates with 25 hospitals and clinics in the Minneapolis-St. Paul area and surrounding suburbs. It boasts over 160 physician-researchers specializing in various oncology fields. Currently, MMCORC is conducting more than 100 open clinical trials targeting specific types of cancer.